Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating ...

Aurinia Pharmaceuticals posts record Lupkynis sales, addresses FDA queries with new data, and faces new competition from ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

As of Tuesday, December 16, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 8.47%, which has investors ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

A user on X shared that his relative found an old share certificate of Burroughs Wellcome India Ltd, purchased in 1993.

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

On Friday, Steve Berman and his firm, Hagens Berman, petitioned the U.S. Court of Appeals for the Third Circuit to disqualify ...

IDEAYA Biosciences ( ($IDYA) ) has shared an update. On December 4, 2025, GlaxoSmithKline announced its decision to terminate its collaboration ...